Latest period
$44.5B
YoY change
-7.9%
5Y CAGR
-1.8%
Peak year (FY2020)
$51.7B
Latest annual
$47.1B
Total Debt history chart for Bristol-Myers Squibb (BMY) from 2016 to 2025
Latest: $47.1B
Total Debt growth chart for Bristol-Myers Squibb (BMY) from 2016 to 2025
Latest: -7.9%
Total Debt history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| FY2025 | $47.1B | -7.9% | -$4.06B | ||
| FY2024 | $51.2B | +23.5% | +$9.74B | ||
| FY2023 | $41.5B | +1.8% | +$747M | ||
| FY2022 | $40.7B | -10.7% | -$4.88B | ||
| FY2021 | $45.6B | -11.8% | -$6.08B | ||
| FY2020 | $51.7B | +8.7% | +$4.14B | ||
| FY2019 | $47.5B | +546.9% | +$40.2B | ||
| FY2018 | $7.35B | -7.7% | -$613M | ||
| FY2017 | $7.96B | +18.7% | +$1.25B | ||
| FY2016 | $6.71B | +0.3% | +$19M | ||
| FY2015 | $6.69B | -14.6% | -$1.14B | ||
| FY2014 | $7.83B | -6.1% | -$508M | ||
| FY2013 | $8.34B | +12.8% | +$946M | ||
| FY2012 | $7.39B | +34.7% | +$1.9B | ||
| FY2011 | $5.49B | +0.8% | +$46M | ||
| FY2010 | $5.45B | -14.4% | -$916M | ||
| FY2009 | $6.36B | -5.6% | -$378M | ||
| FY2008 | $6.74B | +7.4% | +$467M | ||
| FY2007 | $6.27B | -15.6% | -$1.16B | ||
| FY2006 | $7.44B | -13.5% | -$1.16B | ||
| FY2005 | $8.6B | -16.9% | -$1.75B | ||
| FY2004 | $10.3B | +18.2% | +$1.59B | ||
| FY2003 | $8.75B | +14.6% | +$1.11B | ||
| FY2002 | $7.64B | +19.2% | +$1.23B | ||
| FY2001 | $6.41B | +328.0% | +$4.91B | ||
| FY2000 | $1.5B | -15.6% | -$276M | ||
| FY1999 | $1.77B | -3.9% | -$72M | ||
| FY1998 | $1.85B | +1.3% | +$24M | ||
| FY1997 | $1.82B | +23.2% | +$343M | ||
| FY1996 | $1.48B | +22.2% | +$269M | ||
| FY1995 | $1.21B | -11.6% | -$159M | ||
| FY1994 | $1.37B | +79.0% | +$604M | ||
| FY1993 | $765M | +38.8% | +$214M | ||
| FY1992 | $551M | -19.9% | -$137M | ||
| FY1991 | $688M | +9.6% | +$60M | ||
| FY1990 | $628M | +21.2% | +$110M | ||
| FY1989 | $518M | -46.2% | -$445M | ||
| FY1988 | $963M | +38.8% | +$269M | ||
| FY1987 | $694M | — | — |
- FY2025$47.1B-7.9%
- FY2024$51.2B+23.5%
- FY2023$41.5B+1.8%
- FY2022$40.7B-10.7%
- FY2021$45.6B-11.8%
- FY2020$51.7B+8.7%
- FY2019$47.5B+546.9%
- FY2018$7.35B-7.7%
- FY2017$7.96B+18.7%
- FY2016$6.71B+0.3%
- FY2015$6.69B-14.6%
- FY2014$7.83B-6.1%
- FY2013$8.34B+12.8%
- FY2012$7.39B+34.7%
- FY2011$5.49B+0.8%
- FY2010$5.45B-14.4%
- FY2009$6.36B-5.6%
- FY2008$6.74B+7.4%
- FY2007$6.27B-15.6%
- FY2006$7.44B-13.5%
- FY2005$8.6B-16.9%
- FY2004$10.3B+18.2%
- FY2003$8.75B+14.6%
- FY2002$7.64B+19.2%
- FY2001$6.41B+328.0%
- FY2000$1.5B-15.6%
- FY1999$1.77B-3.9%
- FY1998$1.85B+1.3%
- FY1997$1.82B+23.2%
- FY1996$1.48B+22.2%
- FY1995$1.21B-11.6%
- FY1994$1.37B+79.0%
- FY1993$765M+38.8%
- FY1992$551M-19.9%
- FY1991$688M+9.6%
- FY1990$628M+21.2%
- FY1989$518M-46.2%
- FY1988$963M+38.8%
- FY1987$694M—
Total Debt values are taken from Bristol-Myers Squibb's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total debt is $44.5B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Bristol-Myers Squibb (BMY) total debt is $47.1B – declined 7.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bristol-Myers Squibb total debt compounded at -1.8% per year, with a net decline across the window.
The record annual total debt stands at $51.7B, reached in 2020; the historical low of $518M was recorded in 1989.
Bristol-Myers Squibb Total Debt by Year
Bristol-Myers Squibb Total Debt 2025: $47.1B
2025's total debt for Bristol-Myers Squibb came in at $47.1B, declined 7.9% below 2024.
Bristol-Myers Squibb Total Debt 2024: $51.2B
Bristol-Myers Squibb posted total debt of $51.2B in 2024, grew 23.5% from 2023.
Bristol-Myers Squibb Total Debt 2023: $41.5B
In 2023, Bristol-Myers Squibb reported total debt of $41.5B, edged up 1.8% from 2022.
Bristol-Myers Squibb Total Debt 2022: $40.7B
Bristol-Myers Squibb total debt in 2022 was $40.7B, declined 10.7% below 2021.
Bristol-Myers Squibb Total Debt 2021: $45.6B
Bristol-Myers Squibb total debt in 2021 was $45.6B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by Total Debt
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest total debt
| $78.4B | |
| $69.1B | |
| $54.6B | |
| $50.5B | |
| $47.9B | |
| $42.5B | |
| $40.9B | |
| $20.6B |
- $78.4B
- $69.1B
- $54.6B
- $50.5B
- $47.9B
- $42.5B
- $20.6B
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.08% TTM
- Dividend Profile3.98% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.